Viewing a single comment thread. View all comments

fhwulala t1_itaw2ks wrote

With radioligands for pancreatic cancer already on the market, the bar would be pretty high. Hopefully it can achieve similar survival benefit with less myelosuppression.

1

WeakComparison8347 t1_itkwxbz wrote

Hi what is it about the Radioligands? Does it also work if the genetic tests are negative?

1

fhwulala t1_itl05w1 wrote

The radioligands targets receptors and surface antigens, I am assuming that's what you meant by genetic tests. Unfortunately they are not useful if the tumor cells lacks those targets, perhaps that's where this technology may be useful.

1